Market Closed -
Other stock markets
|
After market 11:20:00 am | |||
2,041 DKK | +0.74% | 2,041 | 0.00% |
May. 15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
May. 15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Analyst Reco.